Ossiam Purchases 306,895 Shares of The Cooper Companies, Inc. $COO

Ossiam raised its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 5,978.9% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 312,028 shares of the medical device company’s stock after acquiring an additional 306,895 shares during the period. Ossiam’s holdings in Cooper Companies were worth $21,393,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Wellington Management Group LLP boosted its holdings in shares of Cooper Companies by 332.9% in the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after acquiring an additional 4,756,178 shares in the last quarter. Sustainable Growth Advisers LP bought a new stake in Cooper Companies during the 2nd quarter worth approximately $240,881,000. Capital World Investors increased its holdings in Cooper Companies by 25.7% during the 3rd quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock valued at $723,417,000 after purchasing an additional 2,159,233 shares in the last quarter. Ameriprise Financial Inc. increased its holdings in Cooper Companies by 98.8% during the 2nd quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company’s stock valued at $241,120,000 after purchasing an additional 1,683,561 shares in the last quarter. Finally, Franklin Resources Inc. raised its position in Cooper Companies by 7,723.3% in the 2nd quarter. Franklin Resources Inc. now owns 1,569,512 shares of the medical device company’s stock valued at $111,686,000 after purchasing an additional 1,549,450 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently commented on the company. Wall Street Zen upgraded Cooper Companies from a “hold” rating to a “buy” rating in a report on Saturday, February 28th. Robert W. Baird lifted their price target on Cooper Companies from $85.00 to $98.00 and gave the company an “outperform” rating in a report on Friday, December 5th. Stifel Nicolaus set a $95.00 price target on shares of Cooper Companies and gave the stock a “buy” rating in a research report on Friday, December 5th. Weiss Ratings raised shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, January 12th. Finally, Barclays raised their price objective on shares of Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday, March 6th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Cooper Companies currently has an average rating of “Moderate Buy” and a consensus target price of $90.79.

Insider Activity

In other Cooper Companies news, Director Cynthia L. Lucchese purchased 1,784 shares of the stock in a transaction dated Monday, December 22nd. The stock was bought at an average price of $84.06 per share, for a total transaction of $149,963.04. Following the transaction, the director directly owned 9,445 shares in the company, valued at $793,946.70. This represents a 23.29% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Holly R. Sheffield bought 1,230 shares of the stock in a transaction on Tuesday, December 16th. The shares were acquired at an average cost of $80.75 per share, with a total value of $99,322.50. Following the acquisition, the insider directly owned 39,052 shares in the company, valued at approximately $3,153,449. This trade represents a 3.25% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders purchased 16,014 shares of company stock worth $1,304,416. Corporate insiders own 2.08% of the company’s stock.

Cooper Companies Stock Down 2.2%

NASDAQ COO opened at $69.92 on Friday. The stock has a fifty day moving average of $81.23 and a 200-day moving average of $75.94. The stock has a market capitalization of $13.64 billion, a P/E ratio of 34.61, a price-to-earnings-growth ratio of 1.84 and a beta of 1.02. The Cooper Companies, Inc. has a 52 week low of $61.78 and a 52 week high of $89.83. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.03 by $0.07. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The firm’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.92 earnings per share. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.